APO-Solifenacin solifenacin succinate 5 mg film coated tablets blister

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

solifenacin succinate, Quantity: 5 mg

Disponible des:

Arrotex Pharmaceuticals Pty Ltd

Designació comuna internacional (DCI):

Solifenacin succinate

formulario farmacéutico:

Tablet, film coated

Composición:

Excipient Ingredients: polyvinyl alcohol; croscarmellose sodium; purified talc; titanium dioxide; iron oxide yellow; magnesium stearate; macrogol 8000; lactose; hyprolose

Vía de administración:

Oral

Unidades en paquete:

30

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Solifenacin is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.

Resumen del producto:

Visual Identification: Light yellow coloured, round shaped, biconvex, film-coated tablets, engraved with 'APO' on one side and 'S 5' on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 12 Months; Container Temperature: Store below 30 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2016-01-12